White Paper

Validating The Efficacy Of A Compound With Spatial Imaging

Source: Aliri

By Corinne Ramos, Ph.D. Director, Research and Development, ImaBiotech

GettyImages-1371704947 spatial imaging

In the current drug development environment, sponsors need to affectively generate quality efficacy data to assess drug candidacy. In precision medicine, and in oncology specifically, this process requires an understanding of the potential disease heterogeneity across and within patients and the changes that occur upon drug administration within the tumor microenvironment.

Spatial analysis tools offer a molecular look into the interactions between cells within the context of the disease and provide powerful visualizations into the changes that occur upon drug administration. Discover how target and efficacy validation can translate into substantial savings and market advantages for sponsors as a result of shortened development and approval timelines.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma